Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol doses for post-traumatic intracranial hypertension
NCT00795587Phase 4Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Oct 2008
- Primary completion
- Aug 2011
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Bronchitol in intracranial hypertension (IH), sponsored by CHU Grenoble Alpes. Started Oct 2008; status: terminated.
02
Drugs
Bronchitol
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on NCT00795587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795587.